Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Edema”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Not applicableActive Not RecruitingNCT06075147
What this trial is testing

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Who this might be right for
Visual ImpairmentNeovascular Age-related Macular Degeneration (nAMD)Diabetic Macula Edema (DME)
Bayer 2,500
Not applicableStudy completedNCT02420132
What this trial is testing

Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)

Who this might be right for
Macular EdemaMacular Degeneration
Hoffmann-La Roche 47
Very early researchActive Not RecruitingNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Not applicableStudy completedNCT07105228
What this trial is testing

Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

Who this might be right for
Retinal Vasculitis
Regeneron Pharmaceuticals 290,000
Large-scale testing (Phase 3)Study completedNCT05569148
What this trial is testing

A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 35
Not applicableActive Not RecruitingNCT06929143
What this trial is testing

Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Bayer 3,000
Not applicableNot Yet RecruitingNCT07567898
What this trial is testing

Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates

Who this might be right for
Diabetic Macular EdemaNeovascular (Wet) Age-Related Macular DegenerationIntravitreal Injection
Singapore Eye Research Institute 200
Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Early research (Phase 1)Study completedNCT02530918
What this trial is testing

Study of DS-7080a for the Treatment of Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Daiichi Sankyo 56
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Not applicableStudy completedNCT04543331
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Novartis Pharmaceuticals 572
Testing effectiveness (Phase 2)Active Not RecruitingNCT06664502
What this trial is testing

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-related Macular Degeneration (NVAMD)BRVO - Branch Retinal Vein Occlusion
EyeBiotech Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT07550504
What this trial is testing

Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more
Samsung Bioepis Co., Ltd. 30
Early research (Phase 1)Study completedNCT05105607
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 16
Early research (Phase 1)Study completedNCT02867735
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT00729846
What this trial is testing

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationMacular Edema
California Retina Consultants 22
Post-approval studies (Phase 4)Study completedNCT02843490
What this trial is testing

Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Johannes Gutenberg University Mainz 71
Not applicableEnded earlyNCT02510885
What this trial is testing

SD-OCT Angiography

Who this might be right for
Neovascular Age-related Macular DegenerationAge-related Macular DegenerationDiabetic Retinopathy+2 more
Duke University 39
Load More Results